HPS Included in 2025 DoD Research Program

Oyster Bay, NY – In August, the Senate Appropriations Committee unanimously approved the Defense Appropriations bill in a 28-0 vote. For the first time, the committee report accompanying this bill includes Hermansky-Pudlak Syndrome as an eligible condition for the Peer Reviewed Medical Research Program.

The Peer-Reviewed Medical Research Program (PRMRP), established in fiscal year 1999 (FY99), has supported research across the full range of science and medicine. Its underlying goal is to enhance the health, well-being, and care of military Service Members, Veterans, retirees, and their family members.

The Senate recommended $370 Million for the PRMRP in Fiscal Year 2025. To prepare to utilize this opportunity, please refer to the framework used in 2024.

In Fiscal Year 2024, the PRMRP included six different funding mechanisms: discovery award, investigator-initiated research award, impact award, technology/therapeutic development award, lifestyle and behavioral health interventions research award, and clinical trial awards. Grant letters of intent were due in early May, and complete applications were due in early June-August.

You can learn more about the program at https://cdmrp.health.mil/prmrp/

The HPS Network is committed to leveraging this opportunity to the fullest. We eagerly look forward to collaborating with our science and research community to ensure that this funding is utilized effectively.

Lastly, we would like to extend our heartfelt thanks to our relentless advocates and lawmakers for this opportunity. Your unwavering support and dedication have been instrumental in achieving this milestone. We are excited to see where this research takes us next!

The HPS Network, Inc. is a 501c3 whose mission is to provide education and vital support programs to individuals and families with Hermansky-Pudlak syndrome while striving for improved care and innovative research on our journey to cure.